- Global network
- About us
-
Knowledge hub
Clinical Trial Supply & Logistics
- Clinical Trial Logistics
- Clinical Trial Supply
- Courier Services & Preconditioned Temperature Controlled Packaging
- GxP-Compliant Cold Chain Transport & Storage
- Decentralised Clinical Trials & Direct-to-Patient Logistics
- Labelling of Medicinal Products
- Laboratory Kits Preparation
- Protocol Review & Project Management
Medicines Access & Patient-Oriented Services
Regulatory & Importation Services
01.09.2026
COREX Appoints Jamie Beaumont as Global Head of Clinical Trials Sourcing
COREX has appointed Jamie Beaumont as Global Head of Clinical Trials Sourcing. He will lead the international development of the company’s medicines-sourcing portfolio, supporting clinical trials with comparator and other study medicines, as well as sourcing commercial medicines to support government tenders addressing specific shortages.
Jamie will shape and execute the growth strategy for this portfolio, expand COREX’s international customer base and strengthen relationships with manufacturers and authorised suppliers. By bringing sourcing and logistics closer together, he will help COREX provide customers with a more integrated service, built on qualified supply routes and extending from sourcing through to delivery.
Jamie joins COREX from an established international clinical trial supply specialist, where he most recently led global comparator commercial activities. His experience spans international growth strategy, comparator sourcing, supplier negotiations and cross-functional execution across quality, regulatory and logistics.
This commercial experience is complemented by a strong scientific background. Jamie studied oncology through a Master of Research and PhD at Imperial College London. His work included novel drug development and clinical data projects with government and academic institutions, resulting in several peer-reviewed publications in cancer research.
“COREX knows how to solve supply and logistics problems in markets where delivery can be difficult,” says Andrey Tarakanov, Founder of COREX. “The next step is to take that capability further internationally. Jamie understands the science behind a study, the commercial pressures facing sponsors and the practical realities of sourcing medicines across markets. He will work with our teams and existing relationships to grow this part of the business."
Jamie Beaumont said: “Clinical trials are becoming more international, and medicine supply is becoming more complex. The same disciplines matter when supporting government tenders or responding to shortages: market knowledge, dependable supply routes and reliable execution. COREX is investing in those capabilities internationally. That made this the right time for me to join.”
Jamie will shape and execute the growth strategy for this portfolio, expand COREX’s international customer base and strengthen relationships with manufacturers and authorised suppliers. By bringing sourcing and logistics closer together, he will help COREX provide customers with a more integrated service, built on qualified supply routes and extending from sourcing through to delivery.
Jamie joins COREX from an established international clinical trial supply specialist, where he most recently led global comparator commercial activities. His experience spans international growth strategy, comparator sourcing, supplier negotiations and cross-functional execution across quality, regulatory and logistics.
This commercial experience is complemented by a strong scientific background. Jamie studied oncology through a Master of Research and PhD at Imperial College London. His work included novel drug development and clinical data projects with government and academic institutions, resulting in several peer-reviewed publications in cancer research.
“COREX knows how to solve supply and logistics problems in markets where delivery can be difficult,” says Andrey Tarakanov, Founder of COREX. “The next step is to take that capability further internationally. Jamie understands the science behind a study, the commercial pressures facing sponsors and the practical realities of sourcing medicines across markets. He will work with our teams and existing relationships to grow this part of the business."
Jamie Beaumont said: “Clinical trials are becoming more international, and medicine supply is becoming more complex. The same disciplines matter when supporting government tenders or responding to shortages: market knowledge, dependable supply routes and reliable execution. COREX is investing in those capabilities internationally. That made this the right time for me to join.”